Success Story

Vivodyne pioneers bioengineering tools

Vivodyne, a bio-pharma startup founded by Bioengineering PhD Andrei Georgescu and Penn Engineering Associate Professor of Bioengineering Dan Huh, launched earlier this year and raised $5M in seed capital from Kairos Ventures. 

Vivodyne is creating a platform technology that allows thousands of individually lab-grown, living pieces of human organs to be cultivated at a time. By testing drugs and life-saving biologics directly on these realistic human tissues at an unprecedented scale and resolution, the company believes they can greatly improve the success rates of therapeutics entering clinical trials by being much more certain of their safety and effectiveness ahead of time.

Dan Dongeun Huh
Dan Dongeun Huh
Vivodyne
Skip to content